🔥The 9th Round of Easy Loan, Earn $40 Reward is in progress❗️ ⏰ Promotion Period: January 15th - Feburary 15th, 2025 👉 Register now and check more details at gate.io/campaigns/358

#GUTPressRelease #GUTInTheNews paper by Cas Swarte et al on "Multiple indicators of gut dysbiosis predict all-cause and cause-specific mortality in solid organ transplant recipients" via bit.ly/3LcQlTL Jingyuan Fu @HarmsenHermie WeersmaLab

Time to slice some fresh ideas…gut microbiome ,genes, IBD …great to reunite with our team & look forward for more learnings & collaborations @DrThelma Garima Juyal Arshdeep Singh WeersmaLab Ranko Gacesa @Dr Ajit Sood

(1/6) 📢 New Study Alert! In our randomized controlled trial we compare the gut microbiomes of infants whose mothers received prophylactic antibiotics pre-incision versus post umbilical cord clamping.🤰 doi.org/10.1016/j.chom…

#GUTImage from the paper by Gabriels et al entitled "Fluorescently labelled vedolizumab to visualise drug distribution and mucosal target cells in inflammatory bowel disease" via bit.ly/3YIzWP0 wouter nagengast Research UMCG #IBD #Vedolizumab

Exploring the previously reported gut #microbiome acetyltransferase genes involved in metabolism of 5-ASA in #ibd we could not replicate the original findings from Nature Medicine in our Dutch 1000IBD cohort. More work needed. groningen_microbiome gut.bmj.com/content/early/…

#GUTImage from the paper by Cas Swarte et al on "Multiple indicators of gut dysbiosis predict all-cause and cause-specific mortality in solid organ transplant recipients" via bit.ly/3LcQlTL Jingyuan Fu @HarmsenHermie WeersmaLab

The gut microbiome acetyltransferase genes were involved in the metabolism of 5-ASA in IBD. However, new findings from WeersmaLab et al. didn't replicate the original findings: gut.bmj.com/content/early/…

Join us on October 13 for the presentation of our Top Abstract Prize Awardee, Arno R. Bourgonje: CROHN'S DISEASE AND ULCERATIVE COLITIS EXHIBIT PRE-DIAGNOSTIC ANTIBODY SIGNATURES WITH SHARED AND DIVERGENT CHANGES TOWARDS DISEASE ONSET 🔬 👉 bit.ly/3yIvcOg #UEGWeek

#GUTImage from the #RecentAdvancesInClinicalPractice paper by Arnau Vich Vila et al on "Untargeted faecal metabolomics for the discovery of biomarkers and treatment targets for inflammatory bowel diseases" via bit.ly/4dyIID3 WeersmaLab #IBD

I am incredibly proud that 2 out of the 5 top abstracts #UEGWeek are from our department UMCG (out of >3500 abstracts). Huge congratulations to Arno Bourgonje and Anne van der Waai for their groundbreaking work and this important recognition! @my_UEG Lifelines Research UMCG

Amazing meeting at the Paris Immuno-Oncology Conference 2024! So much food for thought from top leaders in microbiome and immunology: Eran Elinav, lisaderosa, Nicola Segata, WeersmaLab, and more. Honored to present our latest work published in Nature Immunology with Julien C. Marie.

#GUTImage from the #RecentAdvancesInClinicalPractice paper by Arnau Vich Vila et al on "Untargeted faecal metabolomics for the discovery of biomarkers and treatment targets for inflammatory bowel diseases" via bit.ly/4dyIID3 WeersmaLab #IBD

📢 New Study Alert! 📢Happy to share the latest results from the Lifelines NEXT Mother-Infant cohort! (1/8). Here we profile the gut microbiome in 4,577 longitudinal samples from 714 mother-infant pairs, from 12 weeks of pregnancy to 1 year post-birth doi.org/10.21203/rs.3.…

Congratulations to Laura Bolte UMCG. Cum Laude distinction for her PhD studying the relation between #diet #microbiome and #immunity in #ibd and response to immune checkpoint inhibition. Work in her PhD thesis has been published in Nature Medicine Gut Journal and JAMA Oncology

#GUTImage from the #RecentAdvancesInClinicalPractice paper by Arnau Vich Vila et al on "Untargeted faecal metabolomics for the discovery of biomarkers and treatment targets for inflammatory bowel diseases" via bit.ly/4dyIID3 WeersmaLab #IBD

Our Consensus statement on #microbiome testing in clinical practice is out in The Lancet Gastroenterology & Hepatology! authors.elsevier.com/a/1kDP5_u7c5KU… Here we recommend how to standardise the framework for test release (indications, pre-testing protocols, sequencing & analysis, result reporting). A thread🧵⬇️

Dear all, we decided to leave twitter / X You can find us on Bluesky: weersmalab.bsky.social